Voluntary Recall Issued for Batch of Mononine, Hemophilia B Treatment

Voluntary Recall Issued for Batch of Mononine, Hemophilia B Treatment

284110

Voluntary Recall Issued for Batch of Mononine, Hemophilia B Treatment

CSL Behring has issued a voluntary, pharmacy level recall covering one batch of Mononine, its long-standing treatment for preventing and controlling bleedings in people with hemophilia B that is soon to be discontinued. According to the company’s statement, the recall is a precautionary measure due to a manufacturing problem that occurred during the filling process for that batch of Mononine. The potential safety risk to patients already in the possession of this particular lot —…

You must be logged in to read/download the full post.